BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 29654866)

  • 21. Molecular mechanism of sarcopenia and cachexia: recent research advances.
    Sakuma K; Aoi W; Yamaguchi A
    Pflugers Arch; 2017 Jun; 469(5-6):573-591. PubMed ID: 28101649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.
    Narsale AA; Puppa MJ; Hardee JP; VanderVeen BN; Enos RT; Murphy EA; Carson JA
    Oncotarget; 2016 Sep; 7(37):59482-59502. PubMed ID: 27449092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy.
    Castillero E; Nieto-Bona MP; Fernández-Galaz C; Martín AI; López-Menduiña M; Granado M; Villanúa MA; López-Calderón A
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E790-9. PubMed ID: 21304067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
    Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R
    Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice.
    Molinari F; Pin F; Gorini S; Chiandotto S; Pontecorvo L; Penna F; Rizzuto E; Pisu S; Musarò A; Costelli P; Rosano G; Ferraro E
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):954-973. PubMed ID: 29130633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced lung cancer burden by selective immunomodulators elicits improvements in muscle proteolysis and strength in cachectic mice.
    Salazar-Degracia A; Granado-Martínez P; Millán-Sánchez A; Tang J; Pons-Carreto A; Barreiro E
    J Cell Physiol; 2019 Aug; 234(10):18041-18052. PubMed ID: 30851071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia.
    Moore-Carrasco R; Busquets S; Almendro V; Palanki M; López-Soriano FJ; Argilés JM
    Int J Oncol; 2007 May; 30(5):1239-45. PubMed ID: 17390027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Alcohol Consumption Enhances Skeletal Muscle Wasting in Mice Bearing Cachectic Cancers: The Role of TNFα/Myostatin Axis.
    Li Y; Zhang F; Modrak S; Little A; Zhang H
    Alcohol Clin Exp Res; 2020 Jan; 44(1):66-77. PubMed ID: 31657476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
    Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
    Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.
    Judge SM; Wu CL; Beharry AW; Roberts BM; Ferreira LF; Kandarian SC; Judge AR
    BMC Cancer; 2014 Dec; 14():997. PubMed ID: 25539728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide-2 from mouse myostatin precursor protein alleviates muscle wasting in cancer-associated cachexia.
    Ojima C; Noguchi Y; Miyamoto T; Saito Y; Orihashi H; Yoshimatsu Y; Watabe T; Takayama K; Hayashi Y; Itoh F
    Cancer Sci; 2020 Aug; 111(8):2954-2964. PubMed ID: 32519375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF-1 is downregulated in experimental cancer cachexia.
    Costelli P; Muscaritoli M; Bossola M; Penna F; Reffo P; Bonetto A; Busquets S; Bonelli G; Lopez-Soriano FJ; Doglietto GB; Argilés JM; Baccino FM; Rossi Fanelli F
    Am J Physiol Regul Integr Comp Physiol; 2006 Sep; 291(3):R674-83. PubMed ID: 16614058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia.
    Op den Kamp CM; Langen RC; Snepvangers FJ; de Theije CC; Schellekens JM; Laugs F; Dingemans AM; Schols AM
    Am J Clin Nutr; 2013 Sep; 98(3):738-48. PubMed ID: 23902785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.
    Figueras M; Busquets S; Carbó N; Barreiro E; Almendro V; Argilés JM; López-Soriano FJ
    FEBS Lett; 2004 Jul; 569(1-3):201-6. PubMed ID: 15225634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formoterol treatment prevents the effects of endotoxin on muscle TNF/NF-kB, Akt/mTOR, and proteolytic pathways in a rat model. Role of IGF-I and miRNA 29b.
    Martín AI; Gómez-SanMiguel AB; Priego T; López-Calderón A
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E705-E714. PubMed ID: 29969314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting.
    McClung JM; Judge AR; Powers SK; Yan Z
    Am J Physiol Cell Physiol; 2010 Mar; 298(3):C542-9. PubMed ID: 19955483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting.
    Penna F; Bonetto A; Aversa Z; Minero VG; Rossi Fanelli F; Costelli P; Muscaritoli M
    J Cachexia Sarcopenia Muscle; 2016 Jun; 7(3):345-54. PubMed ID: 27239411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic derangements of skeletal muscle from a murine model of glioma cachexia.
    Cui P; Shao W; Huang C; Wu CJ; Jiang B; Lin D
    Skelet Muscle; 2019 Jan; 9(1):3. PubMed ID: 30635036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm.
    Pearen MA; Ryall JG; Lynch GS; Muscat GE
    BMC Genomics; 2009 Sep; 10():448. PubMed ID: 19772666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.
    Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ
    Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.